GL1X · GenesisL1 explorer

Research workbench

Crystal structure of P38 with triazolopyridine

Analyse Crystal structure of P38 with triazolopyridine in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1ZZL
Type
protein
Length
351 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Mitogen-activated protein kinase 14
EC
2.7.1.37
UniProt
Q16539
Ligands
TZY
Pockets
5 · best druggability 0.74

Structure

x-ray diffraction · 1 distinct chain · 40% helix, 13% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMitogen-activated protein kinase 14 (EC 2.7.1.37)protein35140% helix, 13% strandQ16539

Ligands and binding sites

  • TZY · 6-[4-(4-fluorophenyl)-1,3-oxazol-5-yl]-3-isopropyl[1,2,4]triazolo[4,3-a]pyridine · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14910.740.8349TZY
21540.450.7619empty
31230.420.7626empty
4730.300.7318empty
5530.270.7316empty

Compared structures

  • 1ZZL · Crystal structure of P38 with triazolopyridine · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.